{"id":2372,"date":"2023-07-19T13:37:18","date_gmt":"2023-07-19T17:37:18","guid":{"rendered":"https:\/\/www.beaconhealthsystem.org\/medical-professionals\/?post_type=tribe_events&p=2372"},"modified":"2023-10-18T13:42:53","modified_gmt":"2023-10-18T17:42:53","slug":"advancing-the-treatment-of-patients-with-myelofibrosis","status":"publish","type":"tribe_events","link":"https:\/\/www.beaconhealthsystem.org\/medical-professionals\/event\/advancing-the-treatment-of-patients-with-myelofibrosis\/","title":{"rendered":"Advancing the Treatment of Patients With Myelofibrosis"},"content":{"rendered":"

Click HERE to Access Webinar OnDemand Recording\u00a0<\/a><\/p>\n

Click HERE to Access CME Evaluation\u00a0<\/a><\/p>\n

Advancing the Treatment of Patients With Myelofibrosis<\/p>\n

Presented By: Aaron T. Gerds, MD, MS – Associate Professor of Medicine and Deputy Director for Clinical Research, Cleveland Clinic Taussig Cancer Institute<\/p>\n

Learning Objectives:<\/p>\n

\u2022 Review the disease burden experienced by patients with myelofibrosis.
\n\u2022 Initiate treatment based on patient prognosis and characteristics.
\n\u2022 Implement strategies, including modifying therapy, to overcome treatment barriers.
\n\u2022 Describe the safety and efficacy of emerging novel therapies for myelofibrosis.<\/p>\n

\"\"Aaron Gerds, MD, MS, is an associate professor of medicine and deputy director for clinical research at the Cleveland Clinic Taussig Cancer Institute and medical director of the Clinical Research Office for Case Western Reserve University\u2019s Case Comprehensive Cancer Center. Dr. Gerds received his medical degree from Loyola University Chicago Stritch School of Medicine where he also completed his residency. He was awarded a fellowship in hematology\/oncology by the University of Washington\u2019s Fred Hutchinson Cancer Center in Seattle.
\nDr. Gerds\u2019 clinical and research interests focus on optimizing current treatments, and developing new therapies for patients with myeloproliferative disorders and other myeloid neoplasia. He serves as principal investigator for a number of clinical trials.
\nAn active member of the American Society of Hematology, Dr. Gerds participates in both the organization\u2019s Advocacy Leadership Institute and Clinical Research Training Institute. He also chairs the National Comprehensive Cancer Network\u2019s MPN guidelines panel. Dr. Gerds is the author or coauthor of numerous journal articles and abstracts and serves as editor-in-chief of ASH Clinical News.<\/p>\n","protected":false},"excerpt":{"rendered":"

Click HERE to Access Webinar OnDemand Recording\u00a0 Click HERE to Access CME Evaluation\u00a0 Advancing the Treatment of Patients With Myelofibrosis Presented By: Aaron T. Gerds, MD, MS – Associate Professor of Medicine and Deputy Director for Clinical Research, Cleveland Clinic Taussig Cancer Institute Learning Objectives:…<\/p>\n","protected":false},"author":79,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"ep_exclude_from_search":false,"_tribe_events_status":"","_tribe_events_status_reason":"","_tribe_events_is_hybrid":"","_tribe_events_is_virtual":"","_tribe_events_virtual_video_source":"","_tribe_events_virtual_embed_video":"","_tribe_events_virtual_linked_button_text":"","_tribe_events_virtual_linked_button":"","_tribe_events_virtual_show_embed_at":"","_tribe_events_virtual_show_embed_to":[],"_tribe_events_virtual_show_on_event":"","_tribe_events_virtual_show_on_views":"","_tribe_events_virtual_url":"","footnotes":""},"tags":[],"tribe_events_cat":[2,264],"class_list":["post-2372","tribe_events","type-tribe_events","status-publish","hentry","tribe_events_cat-cme-events","tribe_events_cat-on-demand-cme","cat_cme-events","cat_on-demand-cme"],"acf":[],"yoast_head":"\n\n\n\n\n\n\n\n\n\n\n\n